Table 5 Correlation of TIRADS classification with BRAFV600E mutation and final diagnosis in BSRTC I-III categories.

From: Value of TIRADS, BSRTC and FNA-BRAFV600E mutation analysis in differentiating high-risk thyroid nodules

TIRADS

BSRTC I

BSRTC II

BSRTC III

BSRTC I-III

n

BRAFV600E

n

BRAFV600E

n

BRAFV600E

n

BRAFV600E

Malignancy (%)

mutation (%)

mutation (%)

mutation (%)

mutation (%)

3

19

2 (10.5)

24

0

9

0

52

2 (3.8)

2 (3.8)

4A

13

2 (15.3)

8

0

10

3 (30.0)

31

5 (16.1)

7 (22.6)

4B

11

6 (54.5)

6

3 (50.0)

14

11 (78.6)

31

20 (64.5)

21 (67.7)

Total

43

10 (23.3)

38

3 (7.9)

33

14 (42.4)

114

27 (23.7)

30 (26.3)

Back to article page